24-month Prospective, Multicentre, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products in the Prophylactic Treatment of Patients With Haemophilia A (A-SURE)

Trial Profile

24-month Prospective, Multicentre, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products in the Prophylactic Treatment of Patients With Haemophilia A (A-SURE)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Efmoroctocog alfa (Primary) ; Factor VIII
  • Indications Haemophilia A
  • Focus Therapeutic Use
  • Acronyms A-SURE
  • Sponsors Swedish Orphan Biovitrum
  • Most Recent Events

    • 19 Jan 2017 According to a Swedish Orphan Biovitrum media release, first patient has been enrolled in the study.
    • 01 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top